Sleep Supplements: Evidence & How to Choose

Written by Iris

The short answer: “Sleep supplement” is a broad category, not a single type of product. Melatonin, magnesium, ashwagandha, valerian and chamomile have been studied for different people, different sleep outcomes and different lengths of time. No ingredient has strong evidence that it is the best choice for everyone. A useful comparison starts with the sleep outcome you care about, then checks whether the exact material and amount on a label resemble what was actually studied.

This guide covers dietary supplements, not over-the-counter sleep medicines such as sedating antihistamines.

Disclosure: PUKO sells dietary supplements, including a nighttime formula mentioned later in this guide. This article is educational and does not establish that any PUKO finished product has been clinically tested or treats insomnia.

What does “works for sleep” actually mean?

Studies do not all measure the same thing. Some focus on sleep onset latency, or how long it takes to fall asleep. Others measure awakenings after sleep begins, total sleep time, sleep efficiency, subjective sleep quality or next-day functioning. A product can change one measure without improving the others.

The method also matters. A sleep diary and a questionnaire capture a person’s experience. Actigraphy estimates sleep and wake patterns from movement. Polysomnography measures brain waves and other signals in a sleep laboratory. These methods answer related but different questions, so a favorable result on a questionnaire should not be described as proof that every objective sleep measure improved.

Timing and cause matter too. Jet lag and delayed sleep-wake phase involve the body clock. Persistent insomnia can involve learned patterns, stress, health conditions, medications or other causes. The National Center for Complementary and Integrative Health notes that cognitive behavioral therapy for insomnia is strongly recommended for chronic insomnia. Supplements should not replace an evaluation when sleep problems persist, cause major daytime impairment or occur with symptoms such as loud snoring, gasping or unusual nighttime movements.

Editorial illustration with unlabeled bottles, a mineral specimen, botanical roots, chamomile tea and a blank notebook — Editorial illustration for comparing sleep-supplement options.

How do common sleep supplements compare?

This table summarizes the kind of evidence a shopper is likely to encounter. Research conditions are included to make the evidence easier to interpret; they are not dosing instructions.

Ingredient	What has been studied	Main evidence limit	What to check on a label
Melatonin	Circadian-timing situations such as jet lag and delayed sleep-wake phase, plus several insomnia-related outcomes.	Evidence for chronic insomnia is not strong enough to treat it as a universal solution; long-term safety data are limited.	Amount per serving, serving timing, other melatonin sources and interaction warnings.
Magnesium	Subjective sleep quality and insomnia symptoms across multiple salts, amounts and trial durations.	A 2026 systematic review rated the evidence low to very low certainty and found inconsistent subjective and objective results.	The form, the amount of elemental magnesium, serving size and magnesium already obtained from other products.
Ashwagandha	Short trials using particular root extracts, with sleep questionnaires and sometimes actigraphy.	Preparations and amounts vary, trials are generally small and short, and findings do not transfer automatically to every extract.	Plant part, extract name or standardization, amount per serving and relevant health or medication cautions.
Valerian	Subjective sleep and insomnia outcomes in a variety of preparations.	Results are inconsistent, benefit has not been demonstrated clearly and long-term safety is uncertain.	Species, plant part, extract details, serving amount and whether it appears in another nighttime blend.
Chamomile	Tea and extract preparations for sleep quality and related symptoms.	Evidence remains inconclusive, and tea cannot be assumed equivalent to a concentrated extract.	Tea versus extract, exact amount, blend ingredients and allergy cautions, especially with ragweed-family allergies.

What does the evidence say about melatonin?

Melatonin is a hormone involved in circadian timing, which is why evidence can look more favorable when the problem is a shifted body clock. The NCCIH melatonin overview describes evidence for jet lag and delayed sleep-wake phase disorder, while also noting that there is not enough strong evidence to recommend melatonin for chronic insomnia.

That distinction changes how to read a label. More milligrams do not automatically mean a better match. Timing, the reason for use and the amount all affect what a melatonin product is trying to do. Short-term use appears safe for most people, but long-term safety is not well established. Melatonin can also cause daytime drowsiness and requires extra care for some people, including those taking blood thinners or epilepsy medicines, older adults and people who are pregnant or breastfeeding. Discussing it with a qualified professional is especially sensible in those situations.

If your priority is avoiding melatonin altogether, see our separate guide to melatonin and non-melatonin options. It explores that decision in more detail while this guide keeps the broader ingredient comparison in view.

How strong is the evidence for magnesium?

Magnesium is widely marketed for sleep, but the trials are heterogeneous. A 2026 systematic review evaluated 12 main adult randomized trials using different magnesium salts, roughly 75 to 729 mg of elemental magnesium per day and durations from two to 12 weeks. The authors found some modest subjective benefits, but results were inconsistent across subjective and objective measures. They rated the overall certainty low to very low and concluded that evidence was insufficient to support routine magnesium treatment for insomnia.

A 2025 randomized trial of magnesium bisglycinate followed 155 adults with poor sleep for four weeks. The tested material supplied 250 mg elemental magnesium together with 1,523 mg glycine. Insomnia Severity Index scores improved slightly more than placebo—about a 1.6-point adjusted difference—but the effect was small, and other sleep questionnaires did not show significant group-by-time differences. The study was short and did not use objective sleep measurement.

This trial does not prove that every glycinate or bisglycinate product will have the same result. The form, elemental amount, accompanying glycine and study population all matter. On a label, compare elemental magnesium rather than the headline weight of the larger compound. Our sleep supplement label checklist explains that step in more detail.

What should you know about ashwagandha?

Ashwagandha studies use different plant parts and extracts. The NIH Office of Dietary Supplements fact sheet describes limited evidence from short trials suggesting possible sleep benefits, but it also emphasizes that preparations vary. There is no single research amount that applies to every product.

One small 2019 randomized trial studied 60 adults with insomnia for 10 weeks. Participants received 300 mg of a specific root-only KSM-66 extract twice daily or placebo. Sleep onset latency measured by actigraphy and several other outcomes favored the extract, while total sleep time and wake after sleep onset were not statistically significant. The study was small, single-center and short. It should be read as evidence about that particular extract and regimen—not proof for any ashwagandha product or finished blend.

Ashwagandha can cause gastrointestinal symptoms or drowsiness. The NIH fact sheet also describes rare reports of liver injury and cautions involving pregnancy, thyroid conditions and medication interactions. Those factors belong in a buying decision alongside any potential benefit.

What about valerian, chamomile and other popular ingredients?

“Natural” does not describe the quality of evidence or the absence of risk. NCCIH reports that valerian research is inconsistent and has not demonstrated a clear benefit for chronic insomnia; long-term safety is uncertain. Evidence for chamomile is also inconclusive, and people with allergies to ragweed or related plants may react to it.

Research for L-tryptophan and 5-HTP is limited, and serotonin-related interactions are a serious reason to avoid treating them as casual add-ons. Kava has very little sleep research and has been linked to severe liver injury. If a blend includes one of these ingredients, evaluate it by its exact identity and amount rather than by a reassuring front-label phrase.

You may also see L-theanine, lemon balm, glycine or GABA in nighttime formulas. Their popularity alone does not justify assuming that all forms, combinations and outcomes are established. A responsible comparison asks whether the finished label states enough information to connect the product to relevant research—and acknowledges when it does not.

How can you compare two sleep supplements without guessing?

Name the outcome. Are you comparing support for a shifted sleep schedule, time to fall asleep, nighttime waking, subjective sleep quality or next-day function? Avoid using “better sleep” as if it were one measurable result.
Match the material. Look for the chemical form, plant part, extract name and standardization. Research on one standardized extract cannot validate an unnamed powder or a different extract.
Translate the serving. Check the amount per full serving, not just per capsule. For minerals, find the elemental amount. Treat study amounts as context rather than personal directions.
Count overlap. Review multivitamins, mineral products, drink mixes and other nighttime blends so you do not accidentally duplicate the same ingredient.
Check what was actually tested. A single-ingredient trial does not prove that a multi-ingredient finished product works. It also does not reveal whether combining ingredients changes benefit, tolerability or interaction risk.
Use the label and evidence together. Third-party testing and clear ingredient disclosure improve confidence in identity and quantity, but they do not turn weak clinical evidence into strong evidence.

For a printable seven-step process, use the dedicated label-first checklist. If your question is specifically about deep sleep and wearable data, see what deep-sleep evidence can and cannot show.

PUKO Unwind + Sleep bottle with magnesium mineral, ashwagandha root and lemon balm in a nighttime editorial scene

How does PUKO Unwind + Sleep fit into this framework?

PUKO Unwind + Sleep is a melatonin-free nighttime formula. At the time of this review, a two-capsule serving lists 240 mg magnesium as magnesium glycinate chelate, 200 mg KSM-66 ashwagandha root extract standardized to 5% withanolides and 150 mg lemon balm extract.

The useful comparison is exact and limited: the label identifies the magnesium form, elemental amount and branded ashwagandha extract. However, the magnesium bisglycinate trial discussed above used a different daily magnesium condition, and the 2019 KSM-66 trial used 300 mg twice daily as a single research intervention. Neither trial tested this finished PUKO formula. The product therefore should not be described as clinically proven from those ingredient studies.

This is the same standard to apply to any brand. Use ingredient research to understand what has been explored, then use the current label to see whether the material and amount are comparable. Do not fill gaps with assumptions.

When should you stop comparing products and talk to a professional?

Seek professional guidance when sleep trouble is persistent, worsening or affecting safety and daytime function. Evaluation is also important when symptoms suggest sleep apnea or another sleep disorder, or when you are pregnant, breastfeeding, managing a medical condition or taking medicines that could interact with a supplement.

A clinician can help identify the cause of the problem and discuss treatments with stronger evidence. For chronic insomnia, CBT-I has a much stronger evidence base than simply cycling through supplement bottles. That does not make every supplement irrelevant; it keeps the decision proportional to the evidence.

Frequently asked questions

Is there one best sleep supplement?

No. The evidence is ingredient-, preparation-, population- and outcome-specific. A product that is relevant to circadian timing may not address chronic insomnia, and a small improvement in a questionnaire is not the same as a large objective change in sleep.

Can I compare products by milligrams alone?

No. Milligrams are meaningful only when you also know the ingredient form, plant part or extract, standardization, serving size and whether the number refers to the active or elemental amount. More is not automatically better.

Does a clinically studied ingredient make the whole blend clinically proven?

No. Ingredient research may provide context, but it does not establish the effectiveness or safety of a finished combination that was not itself tested.

Are melatonin-free products always safer?

No. Removing melatonin does not remove every potential adverse effect or interaction. Other minerals, herbs and amino acids have their own evidence limits and cautions.